In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of IN8bio Inc (NASDAQ: INAB) was $0.25 for the day, down -4.56% from the previous closing price of $0.26. In other words, the price has decreased by -$4.56 from its previous closing price. On the day, 1.4 million shares were traded.
Ratios:
Our analysis of INAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 1.84. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Laidlaw on March 18, 2024, initiated with a Buy rating and assigned the stock a target price of $7.50.
On August 30, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $14.
Stock Price History:
Over the past 52 weeks, INAB has reached a high of $1.74, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -11.26%, while the 200-Day Moving Average is calculated to be -50.87%.
Shares Statistics:
A total of 81.26M shares are outstanding, with a floating share count of 64.72M. Insiders hold about 20.35% of the company’s shares, while institutions hold 30.34% stake in the company.
